Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Sep 28, 2019
Date Accepted: Jan 19, 2021

The final, peer-reviewed published version of this preprint can be found here:

Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework

Anthony Kouyate RC, Nugent L, Jackson S, Smith MY

Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework

JMIR Res Protoc 2022;11(3):e16430

DOI: 10.2196/16430

PMID: 35315784

PMCID: 8984827

Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Application of a Human Centered Design Framework to Inform the Research Protocol

  • Robin C. Anthony Kouyate; 
  • Lisa Nugent; 
  • Shawna Jackson; 
  • Meredith Y. Smith

ABSTRACT

Background:

Involving chronically ill patients in the management of their health is widely recognized as a vital component of high-quality healthcare. In order to assume the role of informed participants, however, patients need both access to their health information as well as assistance in interpreting such data. Smart phone technology with text messaging (SMS) functionality offers a convenient and minimally demanding mechanism for providing such a dual capability to patients. To date, numerous such digital tools have been developed for use in various chronic and progressive disease conditions, including for rheumatoid arthritis.

Objective:

To describe the application of a human centered design (HCD) approach to inform the development of a framework for a digital health intervention to support symptom management and treatment adherence in rheumatoid arthritis.

Methods:

We reviewed the HCD approach which consists of three phases: understanding, ideation, and implementation. To develop our framework, methods were mapped to the objectives of each phase.

Results:

We developed a four-phase framework that was informed by an HCD approach. The first three phases in the framework, which consisted of understanding, ideation, and implementation, were consistent with the HCD approach. In addition, we added a fourth phase, post-implementation assessment, to enable evaluation of patient engagement and intervention impact on symptom self-management.

Conclusions:

Applying HCD-based methods demands commitment to an iterative approach to intervention design. Each phase of our framework yields critical findings for ensuring that the final product is understandable, acceptable, and feasible, and provides value to the patient such that the intervention is both engaging and positively impacts patient outcomes. Clinical Trial: N/A


 Citation

Please cite as:

Anthony Kouyate RC, Nugent L, Jackson S, Smith MY

Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework

JMIR Res Protoc 2022;11(3):e16430

DOI: 10.2196/16430

PMID: 35315784

PMCID: 8984827

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.